Market News & Trends
Foamix Celebrates Receiving 20th US Patent
Foamix Ltd. recently announced the United States Patent and Trademark Office has granted US Patent No. 8,512,718, Pharmaceutical Composition For Topical Application, describing, inter alia,…
MannKind Satisfies Conditions for $40 Million
MannKind Corporation recently announced that pursuant to a Facility Agreement dated July 1, 2013, between Deerfield Private Design Fund II, L.P. and Deerfield Private Design…
West Introduces the Daikyo D4 Elastomer Formulation
West Pharmaceutical Services, Inc. and partner Daikyo Seiko, Ltd. recently announced the commercial launch of the Daikyo D4 elastomer formulation. To meet the ever-increasing quality…
MultiCell Technologies & Genisphere Evaluate Targeted Delivery of MCT-485 for Cancer
MultiCell Technologies, Inc. and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of liver cancer. MCT-485 is a…
Bio-Path Holdings’ Liposomal Delivery Technology Achieves Major Milestone
Bio-Path Holdings, Inc. recently announced that a scientific assay has confirmed that its lead product candidate BP-100-1.01 (Liposomal Grb-2) inhibits the disease-causing target protein in…
XstalBio Launches CentuRecon to Accelerate the Delivery of Biologic Drugs
XstalBio Ltd recently announced the launch of CentuRecon, a new patented reconstitution technology that has the potential to revolutionize the preparation of high concentration protein…
Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting for Abuse-Deterrent Hydrocodone
Atlantic Pharmaceuticals, Inc.recently announced it has completed a successful Pre-Investigational New Drug Meeting with the FDA on a single-component, immediate -release, abuse-deterrent hydrocodone (ATLP-03). Currently,…
New Syringe Designed to Position More Large-Volume Injectable Drugs for Prefill Administration
BD Medical recently announced the launch of BD Sterifill Advance, a new prefillable polymer syringe specially engineered to deliver large-volume injectable drugs by way of…
arGEN-X Grants Licenses to Antibody Half-Life Extension Technology
arGEN-X recently announced the signing of its second non-exclusive license agreement for its antibody half-life extension technology, NHance. Both licenses granted to date are with…
Adamis Pharmaceuticals Signs Agreement to Acquire 3M’s Technology
Adamis Pharmaceuticals Corporation recently announced it has entered into an agreement to exclusively license and, with additional payment, fully acquire 3M Company's Taper Dry Powder…
Oncobiologics & inVentiv Health Form Strategic Biosimilars Partnership
Oncobiologics, Inc. and inVentiv Health recently announced a broad strategic partnership around clinical development for all assets in Oncobiologic's pipeline. The scope of the partnership…
Piramal Receives IND Approval for Novel DGAT1 Inhibitor
Piramal Enterprises Limited recently announced it has received approval from the USFDA for its Investigational New Drug (IND) P7435. This is a novel, potent, and…
Ensemble Therapeutics Forms Global Strategic Collaboration With Novartis
Ensemble Therapeutics recently announced the initiation of a two-part research and development collaboration with Novartis. The companies have entered into a strategic development agreement for…
EMD Millipore Announces Significant Co-Marketing Agreement
EMD Millipore, the life science division of Merck KGaA of Darmstadt, Germany, recently announced a co-marketing agreement with groninger, a leading provider of filling and…
Mirus Announces Dynamic Nucleic Acid Delivery System
Mirus Bio has expanded its transfection expertise with the development of the TransIT-X2 Dynamic Delivery System, an innovative polymeric system for high efficiency nucleic acid…
Lipocine Makes Reverse Merger Move & Secures $38 Million to Advance Portfolio
Lipocine, Inc. recently announced it has entered into securities purchase agreement with gross proceeds of $38 million for the issuance and sale of approximately 6.3…
Rexahn In-Licenses Breakthrough Delivery Platform
Rexahn Pharmaceuticals, Inc. recently announced it has signed an exclusive license agreement with the University of Maryland, Baltimore (UMB) for a novel drug delivery platform,…
Telegraph Hill Partners Raises $310 Million for Life Science Companies
Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated exclusively to life science and healthcare investing, has had its final closing…
PolyTherics & Antitope Combine to Enable the Development of Better Biopharmaceuticals
PolyTherics Limited recently announced that it has merged with Antitope Limited to create an enlarged group with an extensive suite of services and technologies to…
Foamix Unveils Cutting-Edge Technology Platform for Enhanced Delivery
Foamix Ltd. recently announced the development of a new breakthrough platform technology for targeted drug delivery that can enhance the delivery of drugs to skin…
